NASDAQ:CORT

Corcept Therapeutics Stock Predictions

etoro logo Buy CORT
*Your capital is at risk
$72.65
+1.45 (+2.04%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CORT Prediction Chart

CORT Predictions History

Latest community submissions for CORT.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 17, 2025 Bullish $55.31 V 1
Jan 17, 2025 Bearish $55.31 X 0
Aug 28, 2023 $31.41 -1.01% $32.22 X 97.48% 0
Aug 28, 2023 $31.53 -0.63% $32.22 X 97.86% 0
Skagitqg Skagitqg Merchant
Aug 28, 2023 Bullish $32.22 V 1
May 7, 2019 $12.60 +6.22% $11.86 X 93.78% 0
May 6, 2019 $12.80 +0.31% $12.76 X 99.69% 4
May 6, 2019 $12.30 -3.60% $12.76 X 96.40% 0
May 3, 2019 $12.14 -3.88% $12.63 X 96.12% 0
Apr 24, 2019 $12.16 -0.82% $12.26 X 99.18% 2
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CORT with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CORCEPT THERAPEUTICS INCORPORATED
Corcept Therapeutics
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE